Professor Emerita Tel Aviv University (TAU), formerly Lily and Avraham Gildor Chair and Director of the Adams Super Center for Brain Studies. Currently, Director, Elton Laboratory for Molecular Neuroendocrinology. B.Sc. TAU, Ph.D., Weizmann Institute of Science, postdoc. MIT and Salk Institute. Associate Professor, Weizmann Institute, Fogarty-Scholar-in-Residence, NIH, Humboldt Awardee, Germany. Mentored >80 students. Published ~400 papers (h-index 87 -Google Scholar). Inventor of multiple patents including (NAP, Davunetide), a clinical drug candidate targeted at the rare disease indication, the ADNP syndrome and beyond. Discovered ADNP, essential for brain formation implicated in autism, schizophrenia, Alzheimer’s disease and cancer. NAP is the active site of ADNP. Multiple prizes including Teva Founders Prize, Landau Prizes and best applied scientist, TAU. Ex-President, Israel Society for Neuroscience (Honorary Member), Ex-Member, Council of Higher Education. President, European Society for Neurochemistry. Editor-in-Chief, Journal of Molecular Neuroscience, Vice President, Research and Development, Exonavis Therapeutics.